Clinical pathways in treatment of asthma
- 1 June 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 2 (3) , 183-187
- https://doi.org/10.1097/00130832-200206000-00005
Abstract
Although the number of medications for the treatment of status asthmaticus is relatively limited, strategies for the management of acute asthma vary widely both among and within institutions. The choice of drugs, doses, timing of administration, duration of treatment, and assessment measures are often left to the discretion of individual physicians; plans are often not formulated on the basis of data showing efficacy, but rather on local availability and the experience and preference of physicians. The elimination of treatment that adds cost but not improved quality of care can be an effective strategy to optimize the care of acute asthma.Keywords
This publication has 18 references indexed in Scilit:
- Impact of a pediatric asthma clinical pathway on hospital cost and length of stay*Pediatric Pulmonology, 2001
- Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthmaThe Journal of Pediatrics, 2001
- Effectiveness of a Clinical Pathway for Inpatient Asthma ManagementPediatrics, 2000
- Improved outcomes for hospitalized asthmatic children using a clinical pathwayAnnals of Allergy, Asthma & Immunology, 2000
- A cost-saving algorithm for children hospitalized for status asthmaticus.Archives of Pediatrics & Adolescent Medicine, 1998
- Impact of Clinical Pathways and Practice Guidelines on the Management of Acute Exacerbations of Bronchial AsthmaChest, 1998
- One-Year Experience With an Inpatient Asthma Clinical PathwayArchives of Pediatrics & Adolescent Medicine, 1997
- Specialty Differences in the Management of AsthmaArchives of internal medicine (1960), 1997
- Asthma: Better Outcome at Lower Cost?Chest, 1996
- Results of a Program to Improve the Process of Inpatient Care of Adult AsthmaticsChest, 1996